Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Net Margin (2022 - 2025)

Envoy Medical's Net Margin history spans 4 years, with the latest figure at 17723.81% for Q3 2025.

  • For Q3 2025, Net Margin fell 461667.0% year-over-year to 17723.81%; the TTM value through Sep 2025 reached 12576.44%, down 302249.0%, while the annual FY2024 figure was 8920.89%, 98417.0% up from the prior year.
  • Net Margin for Q3 2025 was 17723.81% at Envoy Medical, down from 8900.0% in the prior quarter.
  • Across five years, Net Margin topped out at 20788.96% in Q2 2023 and bottomed at 57385.0% in Q4 2022.
  • The 4-year median for Net Margin is 12881.36% (2024), against an average of 12214.42%.
  • The largest annual shift saw Net Margin surged 5078184bps in 2023 before it tumbled -2865220bps in 2024.
  • A 4-year view of Net Margin shows it stood at 57385.0% in 2022, then surged by 88bps to 6603.16% in 2023, then tumbled by -78bps to 11745.24% in 2024, then crashed by -51bps to 17723.81% in 2025.
  • Per Business Quant, the three most recent readings for COCH's Net Margin are 17723.81% (Q3 2025), 8900.0% (Q2 2025), and 14869.57% (Q1 2025).